SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
QNRX

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$3.28-$0.08 (-2.35%)
 
Market cap
$6.59M
Insider Score
Health Score
Analyst consensus
Listed since
Aug 1, 2016
Market Cap$6.59M-83.3%
Revenue (ttm)$0
Net Income-$19.68M-42.9%
EPS-$9.15+99.0%
Shares Out2.01M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,312
Open$3.50
Previous Close$3.36
Day's Range$3.18 - $3.54
52-Week Range$3.18 - $23.50
Beta1.64
AnalystsBuy
Price Target$17.00(+418.29%)
Earnings DateMar 25, 2027
-0.57% (1D)
No price history available.

About QNRX

Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX006, a prospective therapy for an additional rare dermatological ailment. The organization maintains its operational base in Ashburn, Virginia.

Address
42127 Pleasant Forest Court, Ashburn, VA, 20148-7349, US
Market Cap
7 million
Employees
4
Industrial Classification
Biotechnology

Quoin Pharmaceuticals, Ltd. Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
10th Percentile Overall Score
QNRX InsiderScore:48 / 99

Quoin Pharmaceuticals, Ltd. scored higher than 10% of companies evaluated by InsiderBuying, and ranked 78th out of 110 stocks in the biotech sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Quoin Pharmaceuticals, Ltd. bought $280.0K of stock across 4 purchases in the last 90 days, the largest of them $100.0K.

Stake Increase

The average purchase added about 79% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$408.61K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Fair
From QNRX’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-2.35%
5 Days
-10.14%
1 Month
-18.20%
6 Months
-31.24%
1 Year
-83.26%

$QNRX stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in QNRX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by QNRX's directors and management

Net Shares Purchased by Insiders−60k−30k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

QNRX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New QNRX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to QNRX from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from QNRX’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
47.73
Analyst Ratings
40% of score
99
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
5
Sells
0
Buy Value
$408.61K
Distinct Buyers
5

Insider Score Trend Over Time

-11.9 since Sep 24
0255075100Sep 24 — Insider Score 59.6Sep 25 — Insider Score 63.7Sep 26 — Insider Score 63.3Sep 27 — Insider Score 63.3Sep 28 — Insider Score 63.6Sep 29 — Insider Score 63.4Sep 30 — Insider Score 63.4Oct 1 — Insider Score 63.0Oct 2 — Insider Score 48.0Oct 3 — Insider Score 62.8Oct 4 — Insider Score 62.7Oct 5 — Insider Score 62.6Oct 6 — Insider Score 62.5Oct 7 — Insider Score 62.3Oct 8 — Insider Score 62.2Oct 9 — Insider Score 62.0Oct 10 — Insider Score 61.9Oct 11 — Insider Score 62.1Oct 12 — Insider Score 62.1Oct 13 — Insider Score 61.9Oct 14 — Insider Score 61.9Oct 15 — Insider Score 61.8Oct 16 — Insider Score 61.6Oct 17 — Insider Score 61.4Oct 18 — Insider Score 61.5Oct 19 — Insider Score 61.5Oct 20 — Insider Score 61.5Oct 21 — Insider Score 61.3Oct 22 — Insider Score 61.3Oct 23 — Insider Score 61.1Oct 24 — Insider Score 61.1Oct 25 — Insider Score 60.8Oct 26 — Insider Score 60.9Oct 27 — Insider Score 60.8Oct 28 — Insider Score 60.9Oct 29 — Insider Score 60.6Oct 30 — Insider Score 59.9Oct 31 — Insider Score 59.9Nov 1 — Insider Score 59.9Nov 2 — Insider Score 59.9Nov 3 — Insider Score 59.6Nov 4 — Insider Score 59.2Nov 5 — Insider Score 58.3Nov 6 — Insider Score 57.6Nov 7 — Insider Score 57.4Nov 8 — Insider Score 57.7Nov 9 — Insider Score 57.8Nov 10 — Insider Score 56.9Nov 11 — Insider Score 56.3Nov 12 — Insider Score 55.9Nov 13 — Insider Score 54.7Nov 14 — Insider Score 53.8Nov 15 — Insider Score 54.0Nov 16 — Insider Score 54.2Nov 17 — Insider Score 52.9Nov 18 — Insider Score 51.5Nov 19 — Insider Score 50.3Nov 20 — Insider Score 48.6Nov 21 — Insider Score 47.6Nov 22 — Insider Score 47.7Sep 24Oct 23Nov 22

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.